Tsujinaka T, Kambayashi J, Kang J, Sakon M, Mori T
Second Department of Surgery, Osaka University Medical School, Japan.
Jpn J Surg. 1988 Jan;18(1):43-6. doi: 10.1007/BF02470845.
The intraoperative management of a dysfibrinogenemic patient with gastric cancer is reported herein. In order to avoid abnormal bleeding, the fibrinogen level during a cancer-operation should be maintained above 60 mg/dl. Cryoprecipitate, however, is not suitable for fibrinogen supplementation because of its short life in vivo.